| Ticker | CERS |
|---|---|
| ISIN | US1570851014 |
| Sector | Atención sanitaria |
| Mercado | Mercado Continuo |
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets...
Cerus opera en el sector Healthcare, industria Medical - Devices.